Benchmark Reiterates Buy on Select Medical Hldgs, Maintains $48 Price Target
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bill Sutherland has reiterated a Buy rating on Select Medical Holdings (NYSE:SEM) and maintained a price target of $48.
August 05, 2024 | 12:53 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst Bill Sutherland has reiterated a Buy rating on Select Medical Holdings (NYSE:SEM) and maintained a price target of $48.
The reiteration of a Buy rating and the maintenance of a $48 price target by a reputable analyst is likely to positively impact investor sentiment and could lead to a short-term increase in SEM's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100